论文部分内容阅读
目的分析美托洛尔联合治疗心律失常45例的临床效果。方法选取我院2015年4月至2016年4月收治的90例心律失常患者作为本次研究对象。使用随机数字表法将90例患者随机分为对照组和观察组各45例,对照组患者使用胺碘酮治疗,观察组患者使用胺碘酮联合美托洛尔治疗。治疗结束后,分析两组患者治疗总有效率及出现并发症或不良反应的概率。结果治疗结束后发现,观察组患者的治疗总有效率明显优于对照组,且出现并发症或不良反应的概率也明显小于对照组,两组数据差异有统计学意义(P<0.05)。结论使用胺碘酮联合美托洛尔治疗心律失常能取得较为显著的疗效,能有效降低并发症和不良反应的发生概率,安全性较高,值得临床推广应用。
Objective To analyze the clinical effect of metoprolol combined with 45 cases of arrhythmia. Methods Ninety patients with arrhythmia admitted from April 2015 to April 2016 in our hospital were selected as the study subjects. Ninety patients were randomly divided into control group and observation group with 45 cases in random number table. Patients in control group were treated with amiodarone. Patients in observation group were treated with amiodarone and metoprolol. After treatment, the total effective rate of treatment and the probability of complications or adverse reactions in both groups were analyzed. Results After treatment, the total effective rate of observation group was significantly better than that of control group, and the probability of complications or adverse reactions was also significantly lower than that of control group. The difference between the two groups was statistically significant (P <0.05). Conclusions The use of amiodarone in combination with metoprolol in the treatment of arrhythmia can achieve a more significant effect, which can effectively reduce the incidence of complications and adverse reactions, and is safe and worthy of clinical application.